Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Officials say the suspect was inside the home of Robin Kaye and her husband during a possible burglary and allegedly used ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Memo warns GOP not to let ObamaCare tax ...

The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.

From doctors’ offices to film screenings to dining room tables, women are talking about their changing bodies during ...

The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...

Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. To continue reading and help Philly news thrive, unlock this exclusive offer for unlimited ...

This latest approval builds on an earlier liquid formulation of generic methimazole for feline hyperthyroidism, which ...

The contrast between the FDA’s clinical lens and the raw realities in the Bonafide study highlights a critical disconnect ...

All 20 US trial sites are now open in the XanaMIA phase 2b/3 trial that is studying oral Xanamem® vs. placebo for 36 weeks, ...

Q2 2025 Earnings Call Transcript July 21, 2025 Operator: Good morning and good afternoon, and welcome to the Novartis Q2 2025 Results Release Conference Call and Live Webcast. [Operator Instructions].

Icotrokinra is currently being developed through a licensing and collaboration agreement between Protagonist and J&J.